Quick Answer
NEUROONE MEDICAL TECHNOLOGIES Corp reported Cash and Equivalents of $6.57 million for fiscal year 2025.
NEUROONE MEDICAL TECHNOLOGIES Corp Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $6.57M | +350.0% |
| 2024 | $1.46M | -72.6% |
| 2023 | $5.32M | -34.8% |
| 2022 | $8.16M | +18.2% |
| 2021 | $6.90M | +71.0% |
| 2020 | $4.04M | +1448.0% |
| 2019 | $260.7K | +1866.4% |
| 2018 | $13.3K | -49.9% |
| 2017 | $26.5K | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $3.56M | +214.0% | -45.8% |
| September 30, 2025 | $6.57M | +350.0% | -18.3% |
| June 30, 2025 | $8.04M | +396.3% | +509.0% |
| March 31, 2025 | $1.32M | -45.8% | +16.4% |
| December 31, 2024 | $1.13M | -57.7% | -22.3% |
| September 30, 2024 | $1.46M | -72.6% | -9.9% |
| June 30, 2024 | $1.62M | -47.5% | -33.5% |
| March 31, 2024 | $2.43M | -32.4% | -9.2% |
- NEUROONE MEDICAL TECHNOLOGIES Corp showed an increase of +350.0% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2017–2025 period, NEUROONE MEDICAL TECHNOLOGIES Corp’s cash and equivalents has grown by 24724.8% (from $26.5 thousand to $6.57 million).
- The most recent figure is from NEUROONE MEDICAL TECHNOLOGIES Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on December 17, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: